Cargando…

Cultural adaptation of a patient decision-aid for insulin therapy

INTRODUCTION: Patient decision-aids (PDAs) support patients in selecting evidence-based treatment options. PDA is useful only if the user understands the content to make personalised decisions. Cultural adaptation is a process of adjusting health messages so that the information is accurate, relevan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Ngiap Chuan, Koong Ying Leng, Agnes, Phoon Kwong Yun, Ian, Wang Zhen, Sinead, Paulpandi, Muthulakshmi, Lee, Yew Kong, Furler, John, Car, Josip, Ng, Chirk Jenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064126/
https://www.ncbi.nlm.nih.gov/pubmed/32152165
http://dx.doi.org/10.1136/bmjopen-2019-033791
_version_ 1783504821975777280
author Tan, Ngiap Chuan
Koong Ying Leng, Agnes
Phoon Kwong Yun, Ian
Wang Zhen, Sinead
Paulpandi, Muthulakshmi
Lee, Yew Kong
Furler, John
Car, Josip
Ng, Chirk Jenn
author_facet Tan, Ngiap Chuan
Koong Ying Leng, Agnes
Phoon Kwong Yun, Ian
Wang Zhen, Sinead
Paulpandi, Muthulakshmi
Lee, Yew Kong
Furler, John
Car, Josip
Ng, Chirk Jenn
author_sort Tan, Ngiap Chuan
collection PubMed
description INTRODUCTION: Patient decision-aids (PDAs) support patients in selecting evidence-based treatment options. PDA is useful only if the user understands the content to make personalised decisions. Cultural adaptation is a process of adjusting health messages so that the information is accurate, relevant and understandable to users from a different population. A PDA has been developed to assist Malaysian patients with secondary drug failure to initiate insulin therapy to control their type 2 diabetes mellitus (T2DM). Likewise, patients with T2DM in neighbouring Singapore face similar barriers in commencing insulin treatment, which a PDA may facilitate decision-making in selecting personalised therapy. OBJECTIVE: The study aimed to explore the views and perceptions of Singaporean primary care providers on the Malaysia PDA to initiate insulin therapy and described the cultural adaptation process used in the design and development of a new PDA, which would be trialled in a Singapore primary healthcare institution. METHOD: Qualitative research method was deployed to conduct one-to-one in-depth interviews of the healthcare providers at the trial site (SingHealth Polyclinics—SHP), including six primary care physicians and four nurses to gather their views and feedbacks on the Malaysian PDA. The interviews were transcribed, audited and analysed (standard content analysis) to identify themes relating to the content, layout, concerns of the original PDA and suggestions to the design of the new SHP PDA. RESULTS: Cultural adaptation of the new PDA includes change to the overall design, graphics (including pictograms), presentation styles, additional contextualised content (personalisation, subheadings, cost and treatment option), modified phrasing of the subtitles and concerns (choice of words) relevant to the new users. CONCLUSION: A PDA on insulin therapy underwent cultural adaptation before its implementation in another population in a neighbouring country. Its relevance and effectiveness will be evaluated in future research.
format Online
Article
Text
id pubmed-7064126
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70641262020-03-20 Cultural adaptation of a patient decision-aid for insulin therapy Tan, Ngiap Chuan Koong Ying Leng, Agnes Phoon Kwong Yun, Ian Wang Zhen, Sinead Paulpandi, Muthulakshmi Lee, Yew Kong Furler, John Car, Josip Ng, Chirk Jenn BMJ Open Diabetes and Endocrinology INTRODUCTION: Patient decision-aids (PDAs) support patients in selecting evidence-based treatment options. PDA is useful only if the user understands the content to make personalised decisions. Cultural adaptation is a process of adjusting health messages so that the information is accurate, relevant and understandable to users from a different population. A PDA has been developed to assist Malaysian patients with secondary drug failure to initiate insulin therapy to control their type 2 diabetes mellitus (T2DM). Likewise, patients with T2DM in neighbouring Singapore face similar barriers in commencing insulin treatment, which a PDA may facilitate decision-making in selecting personalised therapy. OBJECTIVE: The study aimed to explore the views and perceptions of Singaporean primary care providers on the Malaysia PDA to initiate insulin therapy and described the cultural adaptation process used in the design and development of a new PDA, which would be trialled in a Singapore primary healthcare institution. METHOD: Qualitative research method was deployed to conduct one-to-one in-depth interviews of the healthcare providers at the trial site (SingHealth Polyclinics—SHP), including six primary care physicians and four nurses to gather their views and feedbacks on the Malaysian PDA. The interviews were transcribed, audited and analysed (standard content analysis) to identify themes relating to the content, layout, concerns of the original PDA and suggestions to the design of the new SHP PDA. RESULTS: Cultural adaptation of the new PDA includes change to the overall design, graphics (including pictograms), presentation styles, additional contextualised content (personalisation, subheadings, cost and treatment option), modified phrasing of the subtitles and concerns (choice of words) relevant to the new users. CONCLUSION: A PDA on insulin therapy underwent cultural adaptation before its implementation in another population in a neighbouring country. Its relevance and effectiveness will be evaluated in future research. BMJ Publishing Group 2020-03-08 /pmc/articles/PMC7064126/ /pubmed/32152165 http://dx.doi.org/10.1136/bmjopen-2019-033791 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Tan, Ngiap Chuan
Koong Ying Leng, Agnes
Phoon Kwong Yun, Ian
Wang Zhen, Sinead
Paulpandi, Muthulakshmi
Lee, Yew Kong
Furler, John
Car, Josip
Ng, Chirk Jenn
Cultural adaptation of a patient decision-aid for insulin therapy
title Cultural adaptation of a patient decision-aid for insulin therapy
title_full Cultural adaptation of a patient decision-aid for insulin therapy
title_fullStr Cultural adaptation of a patient decision-aid for insulin therapy
title_full_unstemmed Cultural adaptation of a patient decision-aid for insulin therapy
title_short Cultural adaptation of a patient decision-aid for insulin therapy
title_sort cultural adaptation of a patient decision-aid for insulin therapy
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064126/
https://www.ncbi.nlm.nih.gov/pubmed/32152165
http://dx.doi.org/10.1136/bmjopen-2019-033791
work_keys_str_mv AT tanngiapchuan culturaladaptationofapatientdecisionaidforinsulintherapy
AT koongyinglengagnes culturaladaptationofapatientdecisionaidforinsulintherapy
AT phoonkwongyunian culturaladaptationofapatientdecisionaidforinsulintherapy
AT wangzhensinead culturaladaptationofapatientdecisionaidforinsulintherapy
AT paulpandimuthulakshmi culturaladaptationofapatientdecisionaidforinsulintherapy
AT leeyewkong culturaladaptationofapatientdecisionaidforinsulintherapy
AT furlerjohn culturaladaptationofapatientdecisionaidforinsulintherapy
AT carjosip culturaladaptationofapatientdecisionaidforinsulintherapy
AT ngchirkjenn culturaladaptationofapatientdecisionaidforinsulintherapy